Renal Transplant Failure
📧 Sign up to get email alerts when something new happens for Renal Transplant Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD [Phase 3]
This is a Phase 3 randomized trial update evaluating dapagliflozin for renal and cardiovascular outcomes in patients with severe chronic kid…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Heme Arginate in Transplantation Study [Phase 3]
A Phase 3 study of Heme Arginate in renal transplantation (rejection and failure) has been terminated.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: " SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
This clinical trial update reports on the SAVE Study evaluating switching fast-metabolizer kidney transplant recipients from Advagraf to Env…
-
CLINICAL_TRIALS withdrawal · 2025-04-13Clinical Trial Update: Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation [Phase 4]
A Phase 4 trial comparing extended-release versus immediate-release tacrolimus in patients with renal allograft failure was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
A completed clinical trial evaluating AlloSure for monitoring antibody-mediated processes after kidney transplantation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
A clinical trial update announcing ongoing recruitment to expand post-transplant detection and monitoring of HLA-specific antibodies in rena…
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: PDE5i Use in Renal Transplant Recipients [NA]
A clinical trial evaluating PDE5 inhibitors in renal transplant recipients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study. [Phase 2]
Phase 2 pilot prospective study evaluating belatacept (Nulojix) in renal transplant recipients with mild immunologic risk factors, including…
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation [Phase 4]
A Phase 4 clinical trial comparing standard-dose versus reduced-dose tacrolimus in combination with generic mycophenolate mofetil for de nov…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Phase 4]
Phase 4 trial assessing induction strategies with low tacrolimus exposure in kidney transplant patients treated with everolimus or mycopheno…